Press release
Betty Owhor - CEO & Founder of Klugekopf Global Concept & TechBridge Launches a Narrative to Empower African Women Into The Tech Space
Image: https://www.abnewswire.com/upload/2025/02/cb57a837b2d52387906863a80c798ebf.jpg
Lagos & United Kingdom - 25th February, 2024 - Klugekopf TechBridge, an innovative initiative dedicated to closing the gender gap in technology, is officially launching on March 7, 2025. March 7th holds a special significance, as it marks Betty Owhor's birthday. To commemorate this occasion, she has chosen this day as the official launch of the TechBridge program, viewing it as a meaningful way to give back to society. With a deep sense of purpose, she proudly carries the mandate that God has placed in her-to empower women and create pathways for their success in the tech industry.
Having spent years as the only woman-or the only African woman-leading projects in tech, Betty Owhor recognized the systemic barriers preventing women, particularly African women, from advancing in the industry. Through extensive research, she discovered that the primary obstacles include restricted access to opportunities and systemic biases, rather than a lack of talent or ambition. This realization led to the birth of Klugekopf TechBridge, a program designed to bridge this gap.
As a Christian, Betty believes in the power of purpose and service. She has been privileged to be a part of some of the most influential global projects, where she has gained insights and experiences that now fuel her mission to create pathways for other women in tech.
As part of its inaugural initiative, Klugekopf TechBridge will sponsor 20 outstanding women to pursue specialized courses in Artificial Intelligence, Project Management, or Digital Marketing-three fields critical to the future of technology and business.
Join the Launch and First Webinar
To mark this milestone, Klugekopf TechBridge will host its first-ever webinar on March 8, 2025, in celebration of International Women's Day. This event, taking place on Zoom, will feature industry leaders sharing insights and strategies on how women can break into and excel in tech.
Betty Owhor invites the global community to support this movement by spreading the word and encouraging women to register and participate.
Register for the event here: https://lu.ma/9jxy3n5l
For more information about the Klugekopf TechBridge Program, visit our website: www.klugekopftechbridge.com [http://www.klugekopftechbridge.com/]
Media Contact:
Betty Owhor - CEO & Founder, Klugekopf Global Concept
Email: betty@klugekopfglobalconcept.com
Website: https://www.klugekopfglobalconcept.com/
Media Contact
Company Name: Klugekopf Global Concept
Contact Person: Betty Owhor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=betty-owhor-ceo-founder-of-klugekopf-global-concept-techbridge-launches-a-narrative-to-empower-african-women-into-the-tech-space]
Address:21 Hyde Park Road
City: West Yorkshire
State: Leeds LS6 1PY
Country: United Kingdom
Website: https://www.klugekopfglobalconcept.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Betty Owhor - CEO & Founder of Klugekopf Global Concept & TechBridge Launches a Narrative to Empower African Women Into The Tech Space here
News-ID: 3886552 • Views: …
More Releases from ABNewswire
Turn Clients into Referral Partners: LezDo TechMed Reveals Referral-Boosting Tac …
Image: https://www.abnewswire.com/upload/2025/06/0650e44860583acd0f11774a8d988d4d.jpg
LezDo TechMed, a leading litigation support service provider, has released new insights to help Independent Medical Examiners (IMEs) and Qualified Medical Evaluators (QMEs) unlock growth by tapping into an often underused resource resource: their existing clients.
With the increasing competition in the medical evaluation field, finding cost-effective ways to grow a practice is more important than ever. LezDo TechMed's new strategy outlines how evaluators can turn satisfied clients, such as…
SiyanoAV Antivirus: The Trusted Cybersecurity Solution for Small Businesses and …
Image: https://www.abnewswire.com/upload/2025/06/e919a5ad26622108d6c31bcc98b548f4.jpg
In an era where malware, ransomware, and phishing threats loom large, ordinary Windows users and growing businesses can't afford to underprotect their digital environment. Low-cost, lightweight antivirus solutions often fail to deliver crucial protection-or they significantly slow systems down. That's where SiyanoAV Antivirus [https://www.siyanoav.com/] steps in as a smarter choice.
1. Fast, Powerful Protection Without the Drag
* Real-time threat scanning intercepts malware, spyware, and ransomware the moment they appear-without…
Peripheral Arterial Disease Clinical Trials Trials, Companies, Therapeutic Asses …
DelveInsight's, "Peripheral Arterial Disease (PAD)- Pipeline Insight, 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Peripheral Arterial Disease (PAD) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type.
Peripheral Arterial Disease Pipeline constitutes 20+ key companies continuously working towards developing 22+ Peripheral Arterial Disease treatment…
Chimeric Antigen Receptor T-Cell Therapy (CAR-T) Clinical Trials, Companies, The …
DelveInsight's, "Chimeric Antigen Receptor T-Cell Therapy (CAR-T) - Pipeline Insight, 2025" report provides comprehensive insights about 180+ companies and 200+ pipeline drugs in Chimeric Antigen Receptor T-Cell Therapy (CAR-T) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type.
Chimeric Antigen Receptor T-Cell Therapy (CAR-T) Pipeline constitutes 180+ key companies continuously…
